CAS: 1510712-69-2
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl] REF: 3D-KKC71269CAS: 1510712-69-2 | Min. 95% | A consultar | Mié 19 Mar 25 | |
CL264 REF: TM-T10833CAS: 1510712-69-2 | 97.14% | 53,00 €~1.820,00 € | Mié 26 Mar 25 |
Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl]
CAS:1510712-69-2
Please enquire for more information about Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl] including the price, delivery time and more detailed …
Fórmula:
C19H23N7O4
Pureza:
Min. 95%
Peso molecular:
413.4 g/mol
Ref: 3D-KKC71269
10mg | 779,00 € | ||
25mg | 1.374,00 € | ||
50mg | 1.911,00 € |
Entrega estimada en Estados Unidos, el Miércoles 19 de Marzo de 2025
CL264
CAS:1510712-69-2
CL264, a selective agonist of TLR7, can be used in studies about innate immune signals.
Fórmula:
C19H23N7O4
Pureza:
97.14%
Forma y color:
Solid
Peso molecular:
413.43
Ref: TM-T10833
1mg | 53,00 € | ||
5mg | 118,00 € | ||
10mg | 195,00 € | ||
25mg | 308,00 € | ||
50mg | 426,00 € | ||
100mg | 567,00 € | ||
200mg | 765,00 € | ||
1mL*10mM (DMSO) | 130,00 € |
Entrega estimada en Estados Unidos, el Miércoles 26 de Marzo de 2025